Company Update (NYSE:LLY): New Data Show Lilly’s Once-Weekly Trulicity® (dulaglutide) Solution for Injection is Effective as Add-on Treatment to Sulfonylurea

[CNW Group] – New Data Show Lilly’s Once-Weekly Trulicity® (dulaglutide) Solution for Injection is Effective as Add-on Treatment to Sulfonylurea Read more on this. Eli Lilly and Company (LLY), with a current . . . → Read More: Company Update (NYSE:LLY): New Data Show Lilly’s Once-Weekly Trulicity® (dulaglutide) Solution for Injection is Effective as Add-on Treatment to Sulfonylurea Similar Articles: Company Update (NYSE:PRU): Prudential Financial again teams with The Root to produce weekly personal finance show Company Update: Northrop Grumman Corporation (NYSE:NOC) – Northrop Grumman Industry Team Ready to Meet Air Force Requirements with a Cost-Effective Joint STARS Recap Solution Market Update (NYSE:LLY): Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Weeks of Ixekizumab Treatment